Business Description
Unihealth Consultancy Ltd
ISIN : INE0PRF01011
Compare
Compare
Traded in other countries / regions
UNIHEALTH.India IPO Date
2023-09-21Description
Unihealth Consultancy Ltd is a healthcare service provider based out of India and has an operational presence in multiple countries across the African continent. The company is predominantly engaged in the business of medical tour operator, health consultancy services, and also trades medical equipment. Under the brand UMC Hospitals, the company operates healthcare facilities and also provides consultancy services for healthcare projects. It operates across multiple business segments, including hospitals and medical centers which derives key revenue, healthcare consultancy, pharmaceutical and medical consumables distribution, and medical value travel. Geographically, the company generates key revenue from Uganda and the rest from India, Tanzania, United Arab Emirates, and Nigeria.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.88 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 0.84 | |||||
| Interest Coverage | 6.88 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.51 | |||||
| Beneish M-Score | -1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.7 | |||||
| 3-Year EBITDA Growth Rate | 34.4 | |||||
| 3-Year EPS without NRI Growth Rate | 33.7 | |||||
| 3-Year FCF Growth Rate | -12.3 | |||||
| 3-Year Book Growth Rate | 99.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.57 | |||||
| 9-Day RSI | 59.37 | |||||
| 14-Day RSI | 58.03 | |||||
| 6-1 Month Momentum % | 10.8 | |||||
| 12-1 Month Momentum % | 21.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.87 | |||||
| Quick Ratio | 5.68 | |||||
| Cash Ratio | 2.5 | |||||
| Days Inventory | 88.46 | |||||
| Days Sales Outstanding | 228.21 | |||||
| Days Payable | 114.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -13.66 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.25 | |||||
| Operating Margin % | 31.38 | |||||
| Net Margin % | 21.14 | |||||
| FCF Margin % | 4.47 | |||||
| ROE % | 18.25 | |||||
| ROA % | 10.93 | |||||
| ROIC % | 16.22 | |||||
| ROC (Joel Greenblatt) % | 29.27 | |||||
| ROCE % | 19.49 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.83 | |||||
| PE Ratio without NRI | 20.84 | |||||
| Price-to-Owner-Earnings | 704.34 | |||||
| PS Ratio | 4.4 | |||||
| PB Ratio | 2.87 | |||||
| Price-to-Tangible-Book | 3.16 | |||||
| Price-to-Free-Cash-Flow | 98.49 | |||||
| Price-to-Operating-Cash-Flow | 47.09 | |||||
| EV-to-EBIT | 14.67 | |||||
| EV-to-EBITDA | 12.83 | |||||
| EV-to-Revenue | 4.77 | |||||
| EV-to-FCF | 102.81 | |||||
| Price-to-Graham-Number | 1.71 | |||||
| Price-to-Net-Current-Asset-Value | 5.83 | |||||
| Price-to-Net-Cash | 65.47 | |||||
| Earnings Yield (Greenblatt) % | 6.83 | |||||
| FCF Yield % | 0.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Unihealth Consultancy Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 487.5 | ||
| EPS (TTM) (₹) | 7.67 | ||
| Beta | 0 | ||
| Volatility % | 42.35 | ||
| 14-Day RSI | 58.03 | ||
| 14-Day ATR (₹) | 8.355706 | ||
| 20-Day SMA (₹) | 154.8875 | ||
| 12-1 Month Momentum % | 21.06 | ||
| 52-Week Range (₹) | 109 - 175.9 | ||
| Shares Outstanding (Mil) | 15.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Unihealth Consultancy Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Unihealth Consultancy Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Unihealth Consultancy Ltd Frequently Asked Questions
What is Unihealth Consultancy Ltd(NSE:UNIHEALTH)'s stock price today?
The current price of NSE:UNIHEALTH is ₹159.75. The 52 week high of NSE:UNIHEALTH is ₹175.90 and 52 week low is ₹109.00.
When is next earnings date of Unihealth Consultancy Ltd(NSE:UNIHEALTH)?
The next earnings date of Unihealth Consultancy Ltd(NSE:UNIHEALTH) is .
Does Unihealth Consultancy Ltd(NSE:UNIHEALTH) pay dividends? If so, how much?
Unihealth Consultancy Ltd(NSE:UNIHEALTH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers